Axsome Therapeutics, Inc. (AXSM)
183.20
+0.65
(+0.36%)
USD |
NASDAQ |
Feb 09, 16:00
183.20
0.00 (0.00%)
After-Hours: 18:32
Axsome Therapeutics Total Liabilities (Quarterly) : 595.52M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 191.70M |
| Gilead Sciences, Inc. | 37.08B |
| Vanda Pharmaceuticals, Inc. | 135.14M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Amicus Therapeutics, Inc. | 638.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 669.25M |
| Shareholders Equity (Quarterly) | 73.73M |
| Debt to Equity Ratio | 2.965 |
| Current Ratio | 1.569 |
| Net Debt Paydown Yield | -0.09% |